June 16 - Siemens Opens New Molecular Imaging Biomarker Production Centers

Siemens Healthcare has opened two new radiopharmacies in Las Vegas and Pittsburgh. These facilities will produce imaging biomarkers that are a crucial component of PET/CT tests used to diagnose cancer as well as cardiac and neurological ailments.

PETNET Solutions, a fully-owned subsidiary of Siemens Medical Solutions USA, Inc., operates the largest PET radiopharmacy network, with 50 radiopharmacies and distribution centers in the U.S., Korea, and the United Kingdom that produce and distribute PET radiopharmaceuticals to hospitals, clinics, and research facilities. The new facilities produce and supply the required radiopharmaceuticals to area hospitals that have PET/CT.

The Las Vegas facility, which opened in April 2008, will manufacture fluorodeoxyglucose (FDG), the imaging biomarker used to assist with diagnosis and staging of disease processes and to monitor cellular response to treatments, such as chemotherapy and radiotherapy. The Pittsburgh facility also produces FDG.

Source: Siemens Healthcare

(View the Daily News Archive)